Novartis receives European Commission approval of its CAR-T cell therapy, Kymriah® (tisagenlecleucel)

World News: . []

Novartis International AG Novartis LINK  European Commission approval of its CAR-T cell LINK  Kymriah tisagenlecleucel Processed and transmitted by LINK  Corporate SolutionsThe issuer is LINK  responsible for the content of this announc...

More news and information about Novartis International AG

Published By:

Thomson Reuters: 06:15 GMT Monday 27th August 2018

Published: .

Search for other references to "novartis" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us